Norges Bank’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-26,549
Closed -$953K 1853
2024
Q4
$953K Sell
26,549
-14,431
-35% -$540K ﹤0.01% 1763
2024
Q3
$1.55M Sell
40,980
-6,417
-14% -$264K ﹤0.01% 1689
2024
Q2
$2.14M Sell
47,397
-15,611
-25% -$718K ﹤0.01% 1708
2024
Q1
$3.06M Sell
63,008
-12,528
-17% -$614K ﹤0.01% 1696
2023
Q4
$4.05M Sell
75,536
-17,243
-19% -$872K ﹤0.01% 1709
2023
Q3
$5.44M Sell
92,779
-7,928
-8% -$496K ﹤0.01% 1661
2023
Q2
$6.35M Hold
100,707
﹤0.01% 1659
2023
Q1
$6.33M Sell
100,707
-8,041
-7% -$480K ﹤0.01% 1698
2022
Q4
$5.79M Hold
108,748
﹤0.01% 1735
2022
Q3
$6.1M Sell
108,748
-1,361
-1% -$90K ﹤0.01% 1696
2022
Q2
$7.97M Sell
110,109
-9,542
-8% -$711K ﹤0.01% 1647
2022
Q1
$9.51M Hold
119,651
﹤0.01% 1721
2021
Q4
$12.1M Hold
119,651
﹤0.01% 1687
2021
Q3
$11M Hold
119,651
﹤0.01% 1737
2021
Q2
$12.3M Sell
119,651
-16,386
-12% -$1.65M ﹤0.01% 1717
2021
Q1
$13.3M Sell
136,037
-40,878
-23% -$3.72M ﹤0.01% 1701
2020
Q4
$13.6M Sell
176,915
-107,381
-38% -$8.31M ﹤0.01% 1686
2020
Q3
$20.9M Sell
284,296
-38,423
-12% -$3.08M 0.01% 1397
2020
Q2
$23.7M Buy
322,719
+107,188
+50% +$8.41M 0.01% 1333
2020
Q1
$12.4M Buy
215,531
+3,377
+2% +$235K ﹤0.01% 1513
2019
Q4
$16.7M Hold
212,154
﹤0.01% 1613
2019
Q3
$14.5M Sell
212,154
-7,327
-3% -$492K ﹤0.01% 1643
2019
Q2
$17.4M Sell
219,481
-62,057
-22% -$4.92M 0.01% 1582
2019
Q1
$23.6M Sell
281,538
-20,268
-7% -$2.12M 0.01% 1388
2018
Q4
$35.5M Hold
301,806
0.01% 981
2018
Q3
$36.4M Sell
301,806
-19,663
-6% -$2.44M 0.01% 1113
2018
Q2
$37.1M Sell
321,469
-40,345
-11% -$4.41M 0.01% 1064
2018
Q1
$31.1M Sell
361,814
-10,200
-3% -$790K 0.01% 1120
2017
Q4
$27.5M Sell
372,014
-6,545
-2% -$438K 0.01% 1245
2017
Q3
$21.8M Buy
378,559
+170,669
+82% +$10.1M 0.01% 1385
2017
Q2
$13.3M Buy
207,890
+11,122
+6% +$685K 0.01% 1636
2017
Q1
$11.3M Buy
196,768
+84,764
+76% +$5.06M ﹤0.01% 1693
2016
Q4
$6.86M Buy
112,004
+1,960
+2% +$128K ﹤0.01% 1802
2016
Q3
$7.27M Hold
110,044
﹤0.01% 1779
2016
Q2
$6.13M Sell
110,044
-30,558
-22% -$1.84M ﹤0.01% 1814
2016
Q1
$8.54M Hold
140,602
﹤0.01% 1645
2015
Q4
$8.98M Hold
140,602
﹤0.01% 1658
2015
Q3
$9.42M Hold
140,602
﹤0.01% 1601
2015
Q2
$9.61M Hold
140,602
﹤0.01% 1645
2015
Q1
$7.81M Hold
140,602
﹤0.01% 1757
2014
Q4
$7.21M Sell
140,602
-53,956
-28% -$2.65M ﹤0.01% 1786
2014
Q3
$7.17M Sell
194,558
-98,466
-34% -$3.55M ﹤0.01% 1760
2014
Q2
$11.4M Buy
293,024
+146,512
+100% +$5.44M ﹤0.01% 1889
2014
Q1
$5.52M Hold
146,512
﹤0.01% 1860
2013
Q4
$5.54M Hold
146,512
﹤0.01% 1866
2013
Q3
$6.36M Hold
146,512
﹤0.01% 1798
2013
Q2
$5.3M Buy
+146,512
New +$4.45M ﹤0.01% 1815

Other funds holding USNA

Norges Bank's USNA Position: Q1 2025 in Review

Norges Bank sold out of Usana Health Sciences (USNA) in Q1 2025, closing a stake of 26,549 shares — an estimated $953K sold.

Norges Bank first reported a position in USNA in Q2 2013 and held it in 47 quarters. The position peaked at $37.1M in Q2 2018. 162 funds tracked by Wall St. Rank hold USNA as of Q1 2025.

  • Norges Bank reported no remaining Usana Health Sciences position as of Q1 2025 after selling out during the quarter.
  • Norges Bank sold 26,549 Usana Health Sciences shares in Q1 2025, an estimated $953K.
  • Norges Bank first reported a position in Usana Health Sciences in Q2 2013 and held it in 47 quarters.
  • Norges Bank's Usana Health Sciences position peaked at $37.1M in Q2 2018.
  • 162 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2025.

Based on Norges Bank's 13F filing for Q1 2025, filed 13 May 2025.